Interventionelle Therapie von Gefäßmalformationen

Wibke Uller; René Müller-Wille; Walter A. Wohlgemuth

doi:10.1055/s-0034-1393092

Gefäßmedizin Scan - Zeitschrift für Angiologie, Gefäßchirurgie, diagnostische und interventionelle Radiologie, Inhaltsverzeichnis

Gefäßmedizin Scan - Zeitschrift für Angiologie, Gefäßchirurgie, diagnostische und interventionelle Radiologie 2015; 02(04): 305-321
DOI: 10.1055/s-0034-1393092

Fortbildung

Seltene Gefäßerkrankungen

Interventionelle Therapie von Gefäßmalformationen^[*]

Wibke Uller

,

René Müller-Wille

,

Walter A. Wohlgemuth

Abstract

Volltext

Referenzen

Literatur
1 Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982; 69: 412-422
2 Uller W, Müller-Wille R, Wohlgemuth WA. Diagnostik und Klassifikation von Gefäßmalformationen. Intervent Radiol Scan 2013; 3: 235-248
3 Upton J, Coombs CJ, Mulliken JB et al. Vascular malformations of the upper limb: a review of 270 patients. J Hand Surg Am 1999; 24: 1019-1035
4 Berenguer B, Burrows PE, Zurakowski D et al. Sclerotherapy of craniofacial venous malformations: complications and results. Plast Reconstr Surg 1999; 104: 1-11
5 Burrows PE, Mason KP. Percutaneous treatment of low flow vascular malformations. J Vasc Intervent Radiol 2004; 15: 431-445
6 Choi DJ, Alomari AI, Chaudry G et al. Neurointerventional management of low-flow vascular malformations of the head and neck. Neuroimaging Clin N Am 2009; 19: 199-218
7 Burrows PE. Endovascular treatment of slow-flow vascular malformations. Tech Vasc Interv Radiol 2013; 16: 12-21
8 Schumacher M, Dupuy P, Bartoli JM et al. Treatment of venous malformations: first experience with a new sclerosing agent – a multicenter study. Eur J Radiol 2011; 80: 366-372
9 Wollmann JC. Sklerosierungsschaum: Stabilität, physikalische Eigenschaften und rheologisches Verhalten. Phlebologie 2010; 39: 208-217
10 Padwa BL, Hayward PG, Ferraro NF et al. Cervicofacial lymphatic malformation: clinical course, surgical intervention, and pathogenesis of skeletal hypertrophy. Plast Reconstr Surg 1995; 95: 951-960
11 Kaipainen A, Korhonen J, Mustonen T et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 1995; 92: 3566-3570
12 Wigle JT, Oliver G. Prox1 function is required for the development of the murine lymphatic system. Cell 1999; 98: 769-778
13 Smith MC, Zimmerman MB, Burke DK et al. Efficacy and safety of OK-432 immunotherapy of lymphatic malformations. Laryngoscope 2009; 119: 107-115
14 Chaudry G, Guevara CJ, Rialon KL et al. Safety and efficacy of bleomycin sclerotherapy for microcystic lymphatic malformation. Cardiovasc Intervent Radiol 2014; 37: 1476-1481
15 Jacobs AH, Walton RG. The incidence of birthmarks in the neonate. Pediatrics 1976; 58: 218-222
16 Wohlgemuth WA, Wölfle K, Schuster T et al. Angeborene Gefäßmalformationen: Klassifikation, Symptome, Diagnostik und Prognose. Zentralbl Chir 2012; 137: 440-445
17 Cho SK, Do YS, Shin SW et al. Arteriovenous malformations of the body and extremities: analysis of therapeutic outcomes and approaches according to a modified angiographic classification. J Endovasc Ther 2006; 13: 527-538
18 Wohlgemuth WA, Müller-Wille R, Teusch VI et al. The retrograde transvenous push-through method: a novel treatment of peripheral arteriovenous malformations with dominant venous outflow. Cardiovasc Intervent Radiol 2015; 38: 623-631
19 Mallios A, Laurian C, Houbballah R et al. Curative treatment of pelvic arteriovenous malformation – an alternative strategy: transvenous intraoperative embolisation. Eur J Vasc Endovasc Surg 2011; 41: 548-553
20 Kerber C. Intracranial cyanoacrylate: a new catheter therapy for arteriovenous malformation. Invest Radiol 1975; 10: 536-538
21 Vinters HV, Galil KA, Lundie MJ et al. The histotoxicity of cyanoacrylates. A selective review. . Neuroradiology 1985; 27: 279-291
22 Wetter A, Schlunz-Hendann M, Meila D et al. Endovascular treatment of a renal arteriovenous malformation with Onyx. Cardiovasc Intervent Radiol 2012; 35: 211-214
23 Zanjani KS, Mazloumi M, Zeinaloo A et al. Transcatheter embolization of congenital hepatic arteriovenous malformation using ethylene-vinyl alcohol copolymer (Onyx). Diagn Interv Radiol 2012; 18: 231-235
24 Wohlgemuth WA, Uller W, Müller-Wille R. Liquid embolic agents – Onyx as problem solver. Radiologe 2013; 53: 223-229
25 White RI Jr. Pulmonary arteriovenous malformations: How do I embolize?. Tech Vasc Interv Radiol 2007; 10: 283-290
26 Lee BB, Do YS, Yakes W et al. Management of arteriovenous malformations: a multidisciplinary approach. J Vasc Surg 2004; 39: 590-600
27 White RI Jr, Pollak JS, Wirth JA. Pulmonary arteriovenous malformations: diagnosis and transcatheter embolotherapy. J Vasc Interv Radiol 1996; 7: 787-804

Interventionelle Therapie von Gefäßmalformationen[*]

Interventionelle Therapie von Gefäßmalformationen^[*]